Clinical trial

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

NCT00077948

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-07-01

PhasePHASE3

Study timeline

Study start (unknown)2003-07-01Date precision: month

Registry last updated2014-01-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure, Congestiveunresolved

Interventions

Metoprolol succinateDRUG · verified · RxNorm: metoprolol succinate

Placebo to match enoximoneDRUG

Placebo to match metoprolol succinateDRUG

Sponsors & collaborators

Gilead Scienceslead sponsor

AstraZenecacollaborator

Mapped research locations

DenverColorado, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00077948 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.